nodes	percent_of_prediction	percent_of_DWPC	metapath
Procyclidine—CHRM1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000471	0.000471	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000471	0.000471	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00047	0.00047	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00047	0.00047	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00047	0.00047	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000468	0.000468	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000465	0.000465	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000465	0.000465	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—STAR—polycystic ovary syndrome	0.000461	0.000461	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—FST—polycystic ovary syndrome	0.000456	0.000456	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000454	0.000454	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000453	0.000453	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000452	0.000452	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00045	0.00045	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000448	0.000448	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—LHB—polycystic ovary syndrome	0.000445	0.000445	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000443	0.000443	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000442	0.000442	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000441	0.000441	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000439	0.000439	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000438	0.000438	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000435	0.000435	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000435	0.000435	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000428	0.000428	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000426	0.000426	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000422	0.000422	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000421	0.000421	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00042	0.00042	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—SCT—polycystic ovary syndrome	0.000417	0.000417	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000416	0.000416	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000415	0.000415	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000412	0.000412	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—HMMR—polycystic ovary syndrome	0.000411	0.000411	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000411	0.000411	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000406	0.000406	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000404	0.000404	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—INHBB—polycystic ovary syndrome	0.0004	0.0004	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000398	0.000398	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—HSD3B1—polycystic ovary syndrome	0.000392	0.000392	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000391	0.000391	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000388	0.000388	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000382	0.000382	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000379	0.000379	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000377	0.000377	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000374	0.000374	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000369	0.000369	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000368	0.000368	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000364	0.000364	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000362	0.000362	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—LHB—polycystic ovary syndrome	0.000358	0.000358	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000357	0.000357	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—HSD3B2—polycystic ovary syndrome	0.00035	0.00035	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000345	0.000345	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000344	0.000344	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—INSR—polycystic ovary syndrome	0.000341	0.000341	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00034	0.00034	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—AKR1C1—polycystic ovary syndrome	0.000339	0.000339	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000338	0.000338	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000337	0.000337	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000335	0.000335	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000334	0.000334	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000333	0.000333	CbGpPWpGaD
Procyclidine—CHRM2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000332	0.000332	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000331	0.000331	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000324	0.000324	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000324	0.000324	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000323	0.000323	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00032	0.00032	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000319	0.000319	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—PGR—polycystic ovary syndrome	0.000316	0.000316	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000315	0.000315	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000314	0.000314	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—SULT2A1—polycystic ovary syndrome	0.000312	0.000312	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000311	0.000311	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.000307	0.000307	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—FST—polycystic ovary syndrome	0.000306	0.000306	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000306	0.000306	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000305	0.000305	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000304	0.000304	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—FST—polycystic ovary syndrome	0.000303	0.000303	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000303	0.000303	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—RRM2—polycystic ovary syndrome	0.000302	0.000302	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000302	0.000302	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.0003	0.0003	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.0003	0.0003	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—LHB—polycystic ovary syndrome	0.000299	0.000299	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000296	0.000296	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000294	0.000294	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000294	0.000294	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000293	0.000293	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000292	0.000292	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—YAP1—polycystic ovary syndrome	0.000291	0.000291	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000289	0.000289	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000284	0.000284	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000283	0.000283	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000283	0.000283	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000283	0.000283	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000282	0.000282	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000281	0.000281	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00028	0.00028	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00028	0.00028	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—SCT—polycystic ovary syndrome	0.00028	0.00028	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00028	0.00028	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—NAMPT—polycystic ovary syndrome	0.000279	0.000279	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000278	0.000278	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000277	0.000277	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000277	0.000277	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—CYP11A1—polycystic ovary syndrome	0.000276	0.000276	CbGpPWpGaD
Procyclidine—CHRM1—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000275	0.000275	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000274	0.000274	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000273	0.000273	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000272	0.000272	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000268	0.000268	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000267	0.000267	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000265	0.000265	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000264	0.000264	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000263	0.000263	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000261	0.000261	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—AKR1C3—polycystic ovary syndrome	0.000261	0.000261	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00026	0.00026	CbGpPWpGaD
Procyclidine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.00026	0.00026	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.00026	0.00026	CbGpPWpGaD
Procyclidine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000259	0.000259	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000259	0.000259	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000258	0.000258	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000257	0.000257	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000257	0.000257	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—CYP17A1—polycystic ovary syndrome	0.000257	0.000257	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000257	0.000257	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—PRL—polycystic ovary syndrome	0.000256	0.000256	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000254	0.000254	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000247	0.000247	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000244	0.000244	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000243	0.000243	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000243	0.000243	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000241	0.000241	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000241	0.000241	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—GAB1—polycystic ovary syndrome	0.00024	0.00024	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000238	0.000238	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.00023	0.00023	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—INSR—polycystic ovary syndrome	0.000229	0.000229	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000227	0.000227	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000225	0.000225	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—TH—polycystic ovary syndrome	0.000222	0.000222	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000219	0.000219	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000218	0.000218	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—SLC2A4—polycystic ovary syndrome	0.000216	0.000216	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000216	0.000216	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000215	0.000215	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000215	0.000215	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000215	0.000215	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000213	0.000213	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000212	0.000212	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PGR—polycystic ovary syndrome	0.000212	0.000212	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000211	0.000211	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	0.00021	0.00021	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—CYP19A1—polycystic ovary syndrome	0.000203	0.000203	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000198	0.000198	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000198	0.000198	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000197	0.000197	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000197	0.000197	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000195	0.000195	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000195	0.000195	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000191	0.000191	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00019	0.00019	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000189	0.000189	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000188	0.000188	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000188	0.000188	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000187	0.000187	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000184	0.000184	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000184	0.000184	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000183	0.000183	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000183	0.000183	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000182	0.000182	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—GNAS—polycystic ovary syndrome	0.000181	0.000181	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000181	0.000181	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000181	0.000181	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—LEP—polycystic ovary syndrome	0.000177	0.000177	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000174	0.000174	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000174	0.000174	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000173	0.000173	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000173	0.000173	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000173	0.000173	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—NCOR1—polycystic ovary syndrome	0.000173	0.000173	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—PRL—polycystic ovary syndrome	0.000172	0.000172	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000172	0.000172	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000171	0.000171	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000171	0.000171	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000167	0.000167	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000166	0.000166	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000164	0.000164	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000164	0.000164	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—CYP1A1—polycystic ovary syndrome	0.000164	0.000164	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000163	0.000163	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000162	0.000162	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000158	0.000158	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—MTHFR—polycystic ovary syndrome	0.000153	0.000153	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000152	0.000152	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—POMC—polycystic ovary syndrome	0.000152	0.000152	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000152	0.000152	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—INS—polycystic ovary syndrome	0.000151	0.000151	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.00015	0.00015	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000146	0.000146	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000146	0.000146	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000145	0.000145	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000144	0.000144	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000143	0.000143	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000142	0.000142	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000142	0.000142	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	0.00014	0.00014	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000139	0.000139	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—PPARG—polycystic ovary syndrome	0.000124	0.000124	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—POMC—polycystic ovary syndrome	0.000122	0.000122	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000122	0.000122	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000121	0.000121	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—INS—polycystic ovary syndrome	0.000121	0.000121	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	0.00012	0.00012	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000119	0.000119	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—LEP—polycystic ovary syndrome	0.000119	0.000119	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	0.000118	0.000118	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000112	0.000112	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000106	0.000106	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000106	0.000106	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000105	0.000105	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000102	0.000102	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—POMC—polycystic ovary syndrome	0.000102	0.000102	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	0.000102	0.000102	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—INS—polycystic ovary syndrome	0.000101	0.000101	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	0.000101	0.000101	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	0.0001	0.0001	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	9.84e-05	9.84e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	9.84e-05	9.84e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—IGF1—polycystic ovary syndrome	9.81e-05	9.81e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—AKT2—polycystic ovary syndrome	9.81e-05	9.81e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	9.72e-05	9.72e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	9.71e-05	9.71e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—VEGFA—polycystic ovary syndrome	9.54e-05	9.54e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.35e-05	9.35e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.32e-05	9.32e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.23e-05	9.23e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	7.53e-05	7.53e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—IL6—polycystic ovary syndrome	7.5e-05	7.5e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	7.43e-05	7.43e-05	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—IL6—polycystic ovary syndrome	6.6e-05	6.6e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.43e-05	6.43e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.41e-05	6.41e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.35e-05	6.35e-05	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	4.45e-05	4.45e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—IL6—polycystic ovary syndrome	4.43e-05	4.43e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	4.39e-05	4.39e-05	CbGpPWpGaD
